KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Intangibles: 2010-2024

Historic Intangibles for TherapeuticsMD (TXMD) over the last 15 years, with Dec 2024 value amounting to $6.4 million.

  • TherapeuticsMD's Intangibles fell 1.97% to $6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year decrease of 1.97%. This contributed to the annual value of $6.4 million for FY2024, which is 19.95% down from last year.
  • Latest data reveals that TherapeuticsMD reported Intangibles of $6.4 million as of FY2024, which was down 19.95% from $8.0 million recorded in FY2023.
  • In the past 5 years, TherapeuticsMD's Intangibles ranged from a high of $46.0 million in FY2020 and a low of $6.4 million during FY2024.
  • Over the past 3 years, TherapeuticsMD's median Intangibles value was $8.0 million (recorded in 2023), while the average stood at $7.6 million.
  • Its Intangibles has fluctuated over the past 5 years, first spiked by 701.73% in 2020, then tumbled by 82.20% in 2021.
  • Over the past 5 years, TherapeuticsMD's Intangibles (Yearly) stood at $46.0 million in 2020, then crashed by 82.20% to $8.2 million in 2021, then rose by 4.34% to $8.5 million in 2022, then dropped by 6.70% to $8.0 million in 2023, then declined by 19.95% to $6.4 million in 2024.